Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Jones, Lesley ^a   Holmans, Peter A ^a   Hamshere, Marian L ^a   Harold, Denise ^a   Moskvina, Valentina ^a   Ivanov, Dobril ^a   Pocklington, Andrew ^a   Abraham, Richard ^a   Hollingworth, Paul ^a   Sims, Rebecca ^a   Gerrish, Amy ^a   Pahwa, Jaspreet Singh ^a   Jones, Nicola ^a   Stretton, Alexandra ^a   Morgan, Angharad R ^a   Lovestone, Simon ^b   Powell, John ^b   Proitsi, Petroula ^b   Lupton, Michelle K ^b   Brayne, Carol ^c   Rubinsztein, David C ^d   Gill, Michael ^e   Lawlor, Brian ^e   Lynch, Aoibhinn ^e   Morgan, Kevin ^f   Brown, Kristelle S ^f   Passmore, Peter A ^g   Craig, David ^g   Mcguinness, Bernadette ^g   Todd, Stephen ^g   Holmes, Clive ^h   Mann, David ⁱ   Smith, A David ^j   Love, Seth ^k   Kehoe, Patrick G ^k   Mead, Simon ^l   Fox, Nick ^l   Rossor, Martin ^l   Collinge, John ^l   Maier, Wolfgang ^m   Jessen, Frank ^m   Schürmann, Britta ^m   van den Bussche, Hendrik ⁿ   Heuser, Isabella ⁿ   Peters, Oliver ⁿ   Kornhuber, Johannes ^o   Wiltfang, Jens ^p   Dichgans, Martin ^q   Frölich, Lutz ^r   Harald, Hampel ^q,s   Hüll, Michael ^t   Rujescu, Dan ^q   Goate, Alison M ^u   Kauwe, John S K ^v   Cruchaga, Carlos ^u   Nowotny, Petra ^u   Morris, John C ^u   Mayo, Kevin ^u   Livingston, Gill ^w   Bass, Nicholas J ^w   Gurling, Hugh ^w   Mcquillin, Andrew ^w   Gwilliam, Rhian ^x   Deloukas, Panos ^x   Al Chalabi, Ammar ^b   Shaw, Christopher E ^b   Singleton, Andrew B ^y   Guerreiro, Rita ^y   Mühleisen, Thomas W ^m   Nöthen, Markus M ^m   Moebus, Susanne ^z   Jöckel, Karl Heinz ^z   Klopp, Norman ^aa   Wichmann, H Erich ^q,aa,ab   Rüther, Eckhard ^ac   Carrasquillo, Minerva M ^ad   Pankratz, V Shane ^ae   Younkin, Steven G ^ad   Hardy, John ^af   O'Donovan, Michael C ^a   Owen, Michael J ^a   Williams, Julie ^a   more..

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e ST JAMES S HOSPITAL   (Ireland)

^f UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^g QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^h UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

^j UNIVERSITY OF OXFORD   (United Kingdom)

^k UNIVERSITY OF BRISTOL   (United Kingdom)

^l UNIVERSITY COLLEGE LONDON   (United Kingdom)

^m UNIVERSITY OF BONN   (Germany)

ⁿ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^o UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^p UNIVERSITY OF DUISBURG ESSEN   (Germany)

^q LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^r UNIVERSITY OF HEIDELBERG   (Germany)

^s TRINITY COLLEGE DUBLIN   (Ireland)

^t UNIVERSITY OF FREIBURG   (Germany)

^u WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v BRIGHAM YOUNG UNIVERSITY   (United States)

^w UNIVERSITY COLLEGE LONDON   (United Kingdom)

^x WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^y NATIONAL INSTITUTE ON AGING   (United States)

^z UNIVERSITY HOSPITAL ESSEN   (Germany)

^aa INSTITUTE OF EPIDEMIOLOGY   (Germany)

^ab UNIVERSITY OF MUNICH   (Germany)

^ac UNIVERSITY OF GÖTTINGEN   (Germany)

^ad MAYO CLINIC   (United States)

^ae MAYO CLINIC   (United States)

^af UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER A12; ABC TRANSPORTER A7; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN C4; APOLIPOPROTEIN E; COMPLEMENT COMPONENT C9; GENE PRODUCT; INTERLEUKIN 17; PROTEIN ABCA7; PROTEIN ATBA2; PROTEIN ATP8A1; PROTEIN ATP8B4; PROTEIN BCL 3; PROTEIN CLU; PROTEIN LIPC; PROTEIN LIPG; PROTEIN MALL; PROTEIN OSBPL7; PROTEIN OSBPL9; PROTEIN PCTP; PROTEIN SCARB1; PROTEIN VPS4B; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; CHOLESTEROL;

ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LIPID METABOLISM; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMOSOME MAP; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; CHOLESTEROL; CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNE SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78649573450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013950     Document Type: Article

References (40)

1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003) Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60: 1119-1122.
2. Wancata J, Musalek M, Alexandrowicz R, Krautgartner M (2003) Number of dementia sufferers in Europe between the years 2000 and 2050. Eur Psychiatry 18: 306-313.
3. Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, et al. (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63: 168-174.
4. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368: 387-403.
5. Hardy J (2009) The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem 110: 1129-1134.
6. Bertram L (2009) Alzheimer's disease genetics current status and future perspectives. Int Rev Neurobiol 84: 167-184.
7. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics 41: 1088-1093.
8. Lambert J-C, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genomewide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics 41: 1094-1099.
9. Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, et al. (2010) Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet.
10. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, et al. (2010) Replication of CLU, CR1, and PICALM Associations With Alzheimer Disease. Arch Neurol.
11. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, et al. (2010) Common SNPs explain a large proportion of the heritability for human height. Nat Genet.
12. Hirschhorn JN (2009) Genomewide association studies-illuminating biologic pathways. N Engl J Med 360: 1699-1701.
13. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, et al. (2009) Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 18: 2078-2090.
14. Ritchie MD (2009) Using prior knowledge and genome-wide association to identify pathways involved in multiple sclerosis. Genome Med 1: 65.
15. Wang K, Li M, Bucan M (2007) Pathway-Based Approaches for Analysis of Genomewide Association Studies. Am J Hum Genet 81.
16. Holmans P, Green EK, Pahwa JS, Ferreira MA, Purcell SM, et al. (2009) Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 85: 13-24.
17. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
18. Moskvina V, Schmidt KM (2008) On multiple-testing correction in genomewide association studies. Genet Epidemiol 32: 567-573.
19. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, et al. (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32: D258-D261.
20. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, et al. (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34: D354-D357.
21. Bult CJ, Eppig JT, Kadin JA, Richardson JE, Blake JA (2008) The Mouse Genome Database (MGD): mouse biology and model systems. Nucleic Acids Res 36: D724-D728.
22. Simes RJ (1986) Am improved Bonferroni-type procedure for multiple tests of significance. Biometrika 73: 751-754.
23. Hong MG, Pawitan Y, Magnusson PK, Prince JA (2009) Strategies and issues in the detection of pathway enrichment in genome-wide association studies. Hum Genet 126: 289-301.
24. Lambert JC, Grenier-Boley B, Chouraki V, Heath S, Zelenika D, et al. (2010) Implication of the Immune System in Alzheimer's Disease: Evidence from Genome-Wide Pathway Analysis. J Alzheimers Dis.
25. Lambert JC, Grenier-Boley B, Chouraki V, Heath S, Zelenika D, et al. (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
26. Birks J (2006) Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. pp CD005593.
27. Camon EB, Barrell DG, Dimmer EC, Lee V, Magrane M, et al. (2005) An evaluation of GO annotation retrieval for BioCreAtIvE and GOA. BMC Bioinformatics 6 Suppl 1: S17.
28. Reynolds CA, Hong MG, Eriksson UK, Blennow K, Wiklund F, et al. (2010) Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk. Hum Mol Genet 19: 2068-2078.
29. Anstey KJ, Lipnicki DM, Low LF (2008) Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with metaanalysis. Am J Geriatr Psychiatry 16: 343-354.
30. Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12: 1005-1015.
31. Duron E, Hanon O (2008) Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 4: 363-381.
32. Weggen S, Rogers M, Eriksen J (2007) NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development? Trends Pharmacol Sci 28: 536-543.
33. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
34. Bu G (2009) Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10: 333-344.
35. Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, et al. (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58: 681-693.
36. Koudinov AR, Berezov TT, Kumar A, Koudinova NV (1998) Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids. Clin Chim Acta 270: 75-84.
37. McGeer EG, McGeer PL (2001) Innate immunity in Alzheimer's disease: a model for local inflammatory reactions. Mol Interv 1: 22-29.
38. Blasko I, Stampfer-Kountchev M, Robatscher P, Veerhuis R, Eikelenboom P, et al. (2004) How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 3: 169-176.
39. Hanisch UK, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
40. Bates KA, Verdile G, Li QX, Ames D, Hudson P, et al. (2009) Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Mol Psychiatry 14: 469-486.